These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
86 related articles for article (PubMed ID: 12453925)
1. Stereoselective in vitro degradation pattern of mivacurium in human plasma. Laurin J; Donati F; Varin F Br J Anaesth; 2002 Dec; 89(6):832-8. PubMed ID: 12453925 [TBL] [Abstract][Full Text] [Related]
2. The pharmacokinetics and pharmacodynamics of the stereoisomers of mivacurium in patients receiving nitrous oxide/opioid/barbiturate anesthesia. Lien CA; Schmith VD; Embree PB; Belmont MR; Wargin WA; Savarese JJ Anesthesiology; 1994 Jun; 80(6):1296-302. PubMed ID: 8010476 [TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics of mivacurium isomers and their metabolites in healthy volunteers after intravenous bolus administration. Lacroix M; Donati F; Varin F Anesthesiology; 1997 Feb; 86(2):322-30. PubMed ID: 9054251 [TBL] [Abstract][Full Text] [Related]
4. Stereoselective high-performance liquid chromatographic assay with fluorometric detection of the three isomers of mivacurium and their cis- and trans-alcohol and ester metabolites in human plasma. Biederbick W; Aydinciouglou G; Diefenbach C; Theisohn M J Chromatogr B Biomed Appl; 1996 Oct; 685(2):315-22. PubMed ID: 8953173 [TBL] [Abstract][Full Text] [Related]
5. High-performance liquid chromatographic assays with fluorometric detection for mivacurium isomers and their metabolites in human plasma. Lacroix M; Tu TM; Donati F; Varin F J Chromatogr B Biomed Appl; 1995 Jan; 663(2):297-307. PubMed ID: 7735477 [TBL] [Abstract][Full Text] [Related]
6. Rapid method for the quantitation of mivacurium isomers in human and dog plasma by using liquid chromatography with fluorescence detection: application to pharmacokinetic studies. Lugo SI; Eddington ND J Pharm Biomed Anal; 1996 Apr; 14(6):675-83. PubMed ID: 8807542 [TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics of the three isomers of mivacurium and pharmacodynamics of the chiral mixture in hepatic cirrhosis. Head-Rapson AG; Devlin JC; Parker CJ; Hunter JM Br J Anaesth; 1994 Nov; 73(5):613-8. PubMed ID: 7826789 [TBL] [Abstract][Full Text] [Related]
8. Potentiation of mivacurium blockade by low dose of pancuronium: a pharmacokinetic study. Motamed C; Menad R; Farinotti R; Kirov K; Combes X; Bouleau D; Feiss P; Duvaldestin P Anesthesiology; 2003 May; 98(5):1057-62. PubMed ID: 12717125 [TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetic variables of mivacurium chloride after intravenous administration in dogs. Smith LJ; Schwark WS; Cook DR; Moon PF; Looney AL Am J Vet Res; 1999 Sep; 60(9):1051-4. PubMed ID: 10490070 [TBL] [Abstract][Full Text] [Related]
10. The pharmacokinetics and steady state pharmacodynamics of mivacurium in children. Markakis DA; Lau M; Brown R; Luks AM; Sharma ML; Fisher DM Anesthesiology; 1998 Apr; 88(4):978-83. PubMed ID: 9579507 [TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics and pharmacodynamics of mivacurium in patients phenotypically heterozygous for the usual and atypical plasma cholinesterase variants (UA). Østergaard D; Viby-Mogensen J; Rasmussen SN; Gätke MR; Pedersen NA; Skovgaard LT Acta Anaesthesiol Scand; 2003 Nov; 47(10):1219-25. PubMed ID: 14616318 [TBL] [Abstract][Full Text] [Related]
12. Mivacurium arteriovenous gradient during steady state infusion in anesthetized patients. Ezzine S; Donati F; Varin F Anesthesiology; 2002 Sep; 97(3):622-9. PubMed ID: 12218529 [TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics and pharmacodynamics of mivacurium stereoisomers in beagle dogs using twitch height and train-of-four response. Lugo SI; Liang Z; Eddington ND Biopharm Drug Dispos; 1998 Nov; 19(8):485-91. PubMed ID: 9840210 [TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics and pharmacodynamics of the three isomers of mivacurium in health, in end-stage renal failure and in patients with impaired renal function. Head-Rapson AG; Devlin JC; Parker CJ; Hunter JM Br J Anaesth; 1995 Jul; 75(1):31-6. PubMed ID: 7669465 [TBL] [Abstract][Full Text] [Related]
15. An interstitial compartment is necessary to link the pharmacokinetics and pharmacodynamics of mivacurium. Schiere S; Proost JH; Roggeveld J; Wierda M Eur J Anaesthesiol; 2004 Nov; 21(11):882-91. PubMed ID: 15717705 [TBL] [Abstract][Full Text] [Related]
16. In vitro effects of fluoride on pseudocholinesterase activity and the metabolism of the cis-trans and trans-trans isomers of mivacurium. Wiesner G; Gruber M; Keyl C; Schneider A; Drescher J; Hobbhahn J Anesthesiology; 2001 Sep; 95(3):806-7. PubMed ID: 11575562 [No Abstract] [Full Text] [Related]
17. In vitro plasma protein binding of neuromuscular blocking agents in different subpopulations of patients. Cameron M; Donati F; Varin F Anesth Analg; 1995 Nov; 81(5):1019-25. PubMed ID: 7486041 [TBL] [Abstract][Full Text] [Related]
18. Edrophonium requirements for reversal of deep neuromuscular block following infusion of mivacurium. Miller DR; Bryson G; Martineau RJ; Kitts JB; Curran M; Bragg P; Watson JB; Hull K; Lindsay P Can J Anaesth; 1995 Nov; 42(11):996-1002. PubMed ID: 8590511 [TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics and pharmacodynamics of the benzylisoquinolinium muscle relaxants. Hull CJ Acta Anaesthesiol Scand Suppl; 1995; 106():13-7. PubMed ID: 8533537 [TBL] [Abstract][Full Text] [Related]
20. Comparison of the pharmacodynamics and pharmacokinetics of an infusion of cis-atracurium (51W89) or atracurium in critically ill patients undergoing mechanical ventilation in an intensive therapy unit. Boyd AH; Eastwood NB; Parker CJ; Hunter JM Br J Anaesth; 1996 Mar; 76(3):382-8. PubMed ID: 8785138 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]